Therapy Selection, DMT Switching Patterns in Patients With MS
Presenting at CMSC 2022, researchers compared switch treatment patterns and therapy selection decisions between DMTs with anti-CD20 mechanism of action.
Presenting at CMSC 2022, researchers compared switch treatment patterns and therapy selection decisions between DMTs with anti-CD20 mechanism of action.
Researchers sought to screen patients with drug-resistant temporal lobe epilepsy aged 50 years and older and compare surgery outcomes with patients younger than 50 years of age.
Researchers evaluated the prevalence and impact of cognitive impairment on quality of life in patients with SLE.
Researchers sought to provide insight into the potential effect of treatment crossover in the placebo group on the estimated survival effect of sodium phenylbuturate and taurursodiol.
In a clinical trial, researchers assessed the effect of mental practice on mobility rehabilitation in the early subacute phase after stroke compared with a control group.
Researchers sought to characterize the prevalence and clinical features of individuals with both MS and INO in a population-based cohort of patients with MS.
In a systematic review, researchers assessed the evidence for altered interhemispheric inhibition in adults with unilateral conditions, such as stroke.
Researchers sought to assess the risk factors for dementia in older adults with atrial fibrillation.
Researchers sought to assess the clinical prevalence of Alzheimer disease in patients with leprosy, also known as Hansen’s disease, and inflammasome activity.
Researchers sought to assess the change in blood pressure in patients with MS treated with ATZ and prior HDMP treatment compared with patients receiving HDMP only for acute relapse.